MétaCan
Menu
← Back to cohort

Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.

2018· article· en· W2805668121 on OpenAlexaff
Ivana Šestak, Richard Buus, Jack Cuzick, Stephen Barron, Tony Loughman, Bozena Fender, Cesar Lopez Ruiz, Peter Dynoodt, Chan‐Ju Angel Wang, Desmond O’Leary, William M. Gallagher, Mitch Dowsett

Bibliographic record

VenueJournal of Clinical Oncology · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsInstitute of Cancer Research
FundersNational Institutes of HealthScience Foundation IrelandIrish Cancer SocietyEuropean CommissionCancer Research UK
KeywordsMedicineBreast cancerInternal medicineOncologyAnastrozoleProportional hazards modelTamoxifenClinical endpointGynecologyPopulationEstrogen receptorCancerCohortLymph nodeClinical trial

Abstract

fetched live from OpenAlex

553 Background: The assessment of distant recurrence (DR) risk in patients with early estrogen receptor (ER) positive breast cancer receiving adjuvant endocrine therapy is essential in making decisions on additional treatment. OncoMasTR (OM) is a continuous risk prediction model that provides a quantitative assessment of the likelihood of DR in patients with ER-positive breast cancer. The aim of this study was to assess the prognostic performance of OM in predicting DR for postmenopausal patients treated with anastrozole or tamoxifen. Methods: OM incorporates three genes and was developed in an endocrine treated population. OMclinical incorporates clinical parameters into the molecular OM. OM was evaluated for 648 ER-positive, HER2-negative patients with 0 to 3 involved lymph nodes in the TransATAC cohort. DR was the primary endpoint. Cox regression models were used to assess the prognostic performance. OM was evaluated for the overall time period and secondarily for late DR (years 5-10), and in node-negative and node-positive patients separately. Results: OM and OMclinical were highly prognostic for the prediction of DR in years 0-10 among all patients (LRχ2= 25.43 and LRχ2= 48.73, respectively, P < 0.001). OM/OMclinical provided significant additional prognostic value beyond standard clinicopathological variables. In women with node-negative disease, OM identified 37.8% of women as low risk with a 10-year DR risk of 3.5% (1.6-7.7), which was significantly lower compared to those categorised as high risk (10-year DR risk: 16.4% (12.4-21.5); HR = 4.8 (2.0-11.2)). Similar risk stratification and 10-year DR risks were observed for OMclinical in women with node-negative disease (HR = 6.5 (2.6-16.3)). Little prognostic information was provided for node-positive patients. OM and OMclinical were also highly prognostic for the prediction of late DR (LRχ2= 12.84 and LRχ2= 25.61, respectively, P < 0.001). Conclusions: OM and OMclinical were highly prognostic for early and late DR in women with early-stage (particularly node-negative) ER-positive breast cancer receiving 5 years of endocrine therapy and merit further evaluation as risk stratifiers to identify women who can safely forego chemotherapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmano category
Domain: not available · Genre: Empirical
About the Canadian research system: no · About a Canadian topic: no
Observationallow
gptno category
Domain: not available · Genre: Empirical
About the Canadian research system: no · About a Canadian topic: no
Other designlow
models splitAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.396
Teacher spread0.360 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

The models applied no category: nothing in the taxonomy fit this work.

The models disagree on parts of this classification; every voice is preserved in the section at the end of the page.

Study designObservational · Other design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBreast Cancer Treatment Studies→French-language works237,207→